Data as of May 24
| -0.10 / -3.62%|
The 4 analysts offering 12-month price forecasts for Ventrus Biosciences Inc have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +257.14% increase from the last price of 2.66.
The current consensus among 4 polled investment analysts is to Buy stock in Ventrus Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.